16.11.2016 07:30:26

Regulated Information - Ageas reports 9 month results

Positive trend confirmed

9 month 2016  
Net Result
  • Insurance net profit up 31% to EUR 803 million versus EUR 613 million
  • General Account net result of EUR 686 million negative versus EUR 14 million negative
  • Group net result EUR 118 million versus EUR 599 million
Inflows
  • Group inflows (at 100%) EUR 24.7 billion, up 8% (including 4% negative foreign exchange impact)
    Group inflows (Ageas's part) grew 5% to EUR 10.9 billion (including 4% negative foreign exchange impact)
  • Life inflows up 11% to EUR 19.9 billion and Non-Life stable at EUR 4.8 billion (both at 100%)
Operating
Performance
  • Combined ratio 97.0% versus 95.1%
  • Operating Margin Guaranteed 97 bps versus 80 bps
  • Operating Margin Unit-Linked 21 bps versus 37 bps
  • Life Technical Liabilities of the consolidated entities EUR 75.3 billion (+2% compared to the end of 2015)
Balance Sheet
  • Shareholders' equity at EUR 10.5 billion or EUR 50.55 per share
  • Insurance Solvency II ageas ratio 181% and Group Solvency IIageas ratio 199 %
  • General Account Total Liquid Assets at EUR 2.0 billion versus EUR 1.6 billion end 2015
   
Third quarter 2016  
Net Result
  • Insurance net profit up 79% to EUR 196 million versus EUR 109 million
Belgium
  • Excellent Non-Life operating performance marked by a combined ratio of 89.6% and strong operating margins on Life Guaranteed products
UK
  • Gross inflows up in local currency but impacted by the deterioration of the exchange rate
Continental
Europe
  • A solid performance both in Life and Non-Life
Asia
  • Overall excellent third quarter

All 9 month 2016 figures are compared to the 9 month 2015 figures unless otherwise stated.

Ageas CEO Bart De Smet said: "A strong third quarter performance confirmed Ageas's good first half year with solid to excellent results reported across the business. Since the start of the year, the Asian and Belgian businesses have reported consistently strong results, with the Life activities a key driver of growth in the insurance result alongside a good operating performance in Non-Life, specifically in the third quarter in Belgium. At the same time these satisfying results remain supported by very healthy solvency levels, despite the impact of adverse market movements in the third quarter.
During the third quarter, the next step was taken in the Fortis settlement procedure. On 24 March 2017, a public hearing will take place after which the Court of Amsterdam will take a decision on the binding declaration of the settlement."





This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Ageas via Globenewswire

Nachrichten zu ageas NVmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu ageas NVmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

ageas NV 46,40 -0,85% ageas NV